SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sight Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$8.26−0.02 (-0.24%)
Close on Oct 19, 2026
- Market cap
- $450.22M
- P/E (TTM)
- –
- Dividend yield
- –
Sight Sciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Market Cap | $455.03M | $230.55M |
| Enterprise Value | $426.18M | $202.97M |
| PS Ratio | 5.46 | 3.10 |
| PB Ratio | 8.60 | 3.04 |
| P/TBV Ratio | 8.60 | 4.43 |
Enterprise value
| Measure | Sight Sciences | Industry median |
|---|---|---|
| EV / Sales | 5.11 | 2.91 |
Income (trailing twelve months)
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Revenue | $83.38M | $102.39M |
| Gross Profit | $73.34M | $60.36M |
| Operating Income | -$27.88M | -$4.31M |
| Pretax Income | -$29.79M | -$2.37M |
| Net Income | -$29.76M | -$6.57M |
| EBITDA | -$27.47M | -$1.98M |
| EPS (Diluted) | -$0.56 | -$0.08 |
Margins
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Gross Margin | 88.0% | 55.2% |
| Operating Margin | -33.4% | -6.04% |
| Pretax Margin | -35.7% | -4.11% |
| Profit Margin | -35.7% | -10.5% |
| EBITDA Margin | -32.9% | -2.67% |
| FCF Margin | -28.0% | 0.02% |
Returns
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -48.4% | -18.2% |
| Return on Assets (ROA) | -26.2% | -13.3% |
| Return on Invested Capital (ROIC) | -136.0% | -3.69% |
| Return on Capital Employed (ROCE) | -33.0% | -9.07% |
Growth
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 9.27% | 8.85% |
| Revenue Growth (3Y CAGR) | 2.74% | 7.08% |
| Revenue Growth (5Y CAGR) | 22.9% | 11.8% |
Balance sheet
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $79.75M | $36.66M |
| Total Debt | $50.91M | $97.65M |
| Net Cash (Debt) | $28.85M | $3.92M |
| Net Cash Per Share | $0.52 | $0.28 |
| Equity (Book Value) | $52.89M | $55.33M |
| Book Value Per Share | $0.96 | $2.87 |
| Tangible Book Value | $52.89M | $10.79M |
| Working Capital | $80.94M | $56.72M |
Financial position
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Current Ratio | 4.95 | 2.48 |
| Quick Ratio | 4.45 | 1.53 |
| Debt / Equity | 0.96 | 0.41 |
| Interest Coverage | -5.41 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$23.24M | -$566.22K |
| Capital Expenditures | -$93.00K | -$3.69M |
| Free Cash Flow | -$23.33M | -$696.00K |
| FCF Per Share | -$0.42 | -$0.02 |
Efficiency
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Asset Turnover | 0.74 | 0.58 |
| Inventory Turnover | 1.69 | 2.21 |
| Revenue Per Employee | $448.26K | $322.92K |
| Profits Per Employee | -$159.98K | -$51.88K |
| Employee Count | 186 | 185 |
Dividends and yields
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Earnings Yield | -6.54% | -6.88% |
| FCF Yield | -5.13% | -0.45% |
Shares
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 55,088,000 | 44,302,700 |
| Shares Change (YoY) | 4.73% | 3.36% |
| Shares Change (QoQ) | 1.26% | 0.27% |
| Float | 36,770,900 | 37,462,700 |
| Shares Held by Insiders | 33.3% | 10.5% |
| Shares Held by Institutions | 40.2% | 63.5% |
Taxes
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Income Tax | -$32.00K | $1.52M |
Scores
| Measure | Sight Sciences | Industry median |
|---|---|---|
| Altman Z-Score | 0.73 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.01 | -2.64 |
Calculated by StockData from Sight Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.